These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 26585323)

  • 1. The MICA-129Met/Val dimorphism affects plasma membrane expression and shedding of the NKG2D ligand MICA.
    Isernhagen A; Schilling D; Monecke S; Shah P; Elsner L; Walter L; Multhoff G; Dressel R
    Immunogenetics; 2016 Feb; 68(2):109-23. PubMed ID: 26585323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MICA-129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantation.
    Isernhagen A; Malzahn D; Viktorova E; Elsner L; Monecke S; von Bonin F; Kilisch M; Wermuth JM; Walther N; Balavarca Y; Stahl-Hennig C; Engelke M; Walter L; Bickeböller H; Kube D; Wulf G; Dressel R
    EMBO Mol Med; 2015 Nov; 7(11):1480-502. PubMed ID: 26483398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MICA-129 Dimorphism and Soluble MICA Are Associated With the Progression of Multiple Myeloma.
    Zingoni A; Vulpis E; Cecere F; Amendola MG; Fuerst D; Saribekyan T; Achour A; Sandalova T; Nardone I; Peri A; Soriani A; Fionda C; Mariggiò E; Petrucci MT; Ricciardi MR; Mytilineos J; Cippitelli M; Cerboni C; Santoni A
    Front Immunol; 2018; 9():926. PubMed ID: 29765374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the MICA-129Met/Val Dimorphism on NKG2D-Mediated Biological Functions and Disease Risks.
    Isernhagen A; Malzahn D; Bickeböller H; Dressel R
    Front Immunol; 2016; 7():588. PubMed ID: 28018354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Valine Mismatch at Position 129 of
    Michita RT; Chies JAB; Schramm S; Horn PA; Heinemann FM; Wunsch A; Viebahn R; Schenker P; Rebmann V
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30181474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
    Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A
    Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Characterisation and Analysis of the Soluble NKG2D Ligand Repertoire Detected in Umbilical Cord Blood Plasma.
    Cox ST; Danby R; Hernandez D; Laza-Briviesca R; Pearson H; Madrigal JA; Saudemont A
    Front Immunol; 2018; 9():1282. PubMed ID: 29963042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17.
    Chitadze G; Lettau M; Bhat J; Wesch D; Steinle A; Fürst D; Mytilineos J; Kalthoff H; Janssen O; Oberg HH; Kabelitz D
    Int J Cancer; 2013 Oct; 133(7):1557-66. PubMed ID: 23526433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metallopeptidase 2 (MMP2) mediates MHC class I polypeptide-related sequence A (MICA) shedding in renal cell carcinoma.
    Yang FQ; Liu M; Yang FP; Zhang XL; Yang B; Guo CC; Huang JH; Che JP; Yan Y; Zheng JH
    Actas Urol Esp; 2014 Apr; 38(3):172-8. PubMed ID: 24461475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble MICA-NKG2D interaction upregulates IFN-γ production by activated CD3-CD56+ NK cells: potential impact on chronic graft versus host disease.
    Boukouaci W; Al-Daccak R; Dulphy N; Lauden L; Amokrane K; Fortier C; Marzais F; Bennabi M; Peffault de Latour R; Socie G; Toubert A; Charron D; Krishnamoorthy R; Tamouza R
    Hum Immunol; 2013 Dec; 74(12):1536-41. PubMed ID: 23994587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MMP9 mediates MICA shedding in human osteosarcomas.
    Sun D; Wang X; Zhang H; Deng L; Zhang Y
    Cell Biol Int; 2011 Jun; 35(6):569-74. PubMed ID: 21143201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.
    Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M
    FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia downregulates the expression of cell surface MICA without increasing soluble MICA in osteosarcoma cells in a HIF-1α-dependent manner.
    Yamada N; Yamanegi K; Ohyama H; Hata M; Nakasho K; Futani H; Okamura H; Terada N
    Int J Oncol; 2012 Dec; 41(6):2005-12. PubMed ID: 22992985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma.
    Raffaghello L; Prigione I; Airoldi I; Camoriano M; Levreri I; Gambini C; Pende D; Steinle A; Ferrone S; Pistoia V
    Neoplasia; 2004; 6(5):558-68. PubMed ID: 15548365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.
    Pende D; Rivera P; Marcenaro S; Chang CC; Biassoni R; Conte R; Kubin M; Cosman D; Ferrone S; Moretta L; Moretta A
    Cancer Res; 2002 Nov; 62(21):6178-86. PubMed ID: 12414645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a screening method to identify regulators of MICA shedding.
    Kishikawa T; Otsuka M; Ohno M; Yoshikawa T; Sato M; Koike K
    Biochem Biophys Res Commun; 2015 Oct; 465(4):764-8. PubMed ID: 26299929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NKG2D functions as an activating receptor on natural killer cells in the common marmoset (Callithrix jacchus).
    Watanabe M; Kudo Y; Kawano M; Nakayama M; Nakamura K; Kameda M; Ebara M; Sato T; Nakamura M; Omine K; Kametani Y; Suzuki R; Ogasawara K
    Int Immunol; 2014 Nov; 26(11):597-606. PubMed ID: 24860119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of MICA-129 polymorphism with nasopharyngeal cancer risk in a Tunisian population.
    Douik H; Ben Chaaben A; Attia Romdhane N; Romdhane HB; Mamoghli T; Fortier C; Boukouaci W; Harzallah L; Ghanem A; Gritli S; Makni M; Charron D; Krishnamoorthy R; Guemira F; Tamouza R
    Hum Immunol; 2009 Jan; 70(1):45-8. PubMed ID: 19000729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early-onset ankylosing spondylitis is associated with a functional MICA polymorphism.
    Amroun H; Djoudi H; Busson M; Allat R; El Sherbini SM; Sloma I; Ramasawmy R; Brun M; Dulphy N; Krishnamoorthy R; Toubert A; Charron D; Abbadi MC; Tamouza R
    Hum Immunol; 2005 Oct; 66(10):1057-61. PubMed ID: 16386647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Concentrations of Circulating Soluble MHC Class I-Related Chain A (sMICA) and sMICB and Modulation of Plasma Membrane MICA Expression: Potential Mechanisms and Correlation With Natural Killer Cell Activity in Systemic Lupus Erythematosus.
    Hervier B; Ribon M; Tarantino N; Mussard J; Breckler M; Vieillard V; Amoura Z; Steinle A; Klein R; Kötter I; Decker P
    Front Immunol; 2021; 12():633658. PubMed ID: 34012432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.